Cargando…
Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732975/ https://www.ncbi.nlm.nih.gov/pubmed/34562259 http://dx.doi.org/10.1007/s12282-021-01299-w |
| _version_ | 1784627717172363264 |
|---|---|
| author | Koh, Su-Jin Ohsumi, Shozo Takahashi, Masato Fukuma, Eisuke Jung, Kyung Hae Ishida, Takanori Dai, Ming-Shen Chang, Chuan-Hsun Dalvi, Tapashi Walker, Graham Bennett, James O’Shaughnessy, Joyce Balmaña, Judith |
| author_facet | Koh, Su-Jin Ohsumi, Shozo Takahashi, Masato Fukuma, Eisuke Jung, Kyung Hae Ishida, Takanori Dai, Ming-Shen Chang, Chuan-Hsun Dalvi, Tapashi Walker, Graham Bennett, James O’Shaughnessy, Joyce Balmaña, Judith |
| author_sort | Koh, Su-Jin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8732975 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87329752022-01-18 Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study Koh, Su-Jin Ohsumi, Shozo Takahashi, Masato Fukuma, Eisuke Jung, Kyung Hae Ishida, Takanori Dai, Ming-Shen Chang, Chuan-Hsun Dalvi, Tapashi Walker, Graham Bennett, James O’Shaughnessy, Joyce Balmaña, Judith Breast Cancer Correction Springer Singapore 2021-09-25 2022 /pmc/articles/PMC8732975/ /pubmed/34562259 http://dx.doi.org/10.1007/s12282-021-01299-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Koh, Su-Jin Ohsumi, Shozo Takahashi, Masato Fukuma, Eisuke Jung, Kyung Hae Ishida, Takanori Dai, Ming-Shen Chang, Chuan-Hsun Dalvi, Tapashi Walker, Graham Bennett, James O’Shaughnessy, Joyce Balmaña, Judith Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study |
| title | Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study |
| title_full | Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study |
| title_fullStr | Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study |
| title_full_unstemmed | Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study |
| title_short | Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study |
| title_sort | correction to: prevalence of mutations in brca and homologous recombination repair genes and real-world standard of care of asian patients with her2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global breakout study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732975/ https://www.ncbi.nlm.nih.gov/pubmed/34562259 http://dx.doi.org/10.1007/s12282-021-01299-w |
| work_keys_str_mv | AT kohsujin correctiontoprevalenceofmutationsinbrcaandhomologousrecombinationrepairgenesandrealworldstandardofcareofasianpatientswithher2negativemetastaticbreastcancerstartingfirstlinesystemiccytotoxicchemotherapysubgroupanalysisoftheglobalbreakoutstudy AT ohsumishozo correctiontoprevalenceofmutationsinbrcaandhomologousrecombinationrepairgenesandrealworldstandardofcareofasianpatientswithher2negativemetastaticbreastcancerstartingfirstlinesystemiccytotoxicchemotherapysubgroupanalysisoftheglobalbreakoutstudy AT takahashimasato correctiontoprevalenceofmutationsinbrcaandhomologousrecombinationrepairgenesandrealworldstandardofcareofasianpatientswithher2negativemetastaticbreastcancerstartingfirstlinesystemiccytotoxicchemotherapysubgroupanalysisoftheglobalbreakoutstudy AT fukumaeisuke correctiontoprevalenceofmutationsinbrcaandhomologousrecombinationrepairgenesandrealworldstandardofcareofasianpatientswithher2negativemetastaticbreastcancerstartingfirstlinesystemiccytotoxicchemotherapysubgroupanalysisoftheglobalbreakoutstudy AT jungkyunghae correctiontoprevalenceofmutationsinbrcaandhomologousrecombinationrepairgenesandrealworldstandardofcareofasianpatientswithher2negativemetastaticbreastcancerstartingfirstlinesystemiccytotoxicchemotherapysubgroupanalysisoftheglobalbreakoutstudy AT ishidatakanori correctiontoprevalenceofmutationsinbrcaandhomologousrecombinationrepairgenesandrealworldstandardofcareofasianpatientswithher2negativemetastaticbreastcancerstartingfirstlinesystemiccytotoxicchemotherapysubgroupanalysisoftheglobalbreakoutstudy AT daimingshen correctiontoprevalenceofmutationsinbrcaandhomologousrecombinationrepairgenesandrealworldstandardofcareofasianpatientswithher2negativemetastaticbreastcancerstartingfirstlinesystemiccytotoxicchemotherapysubgroupanalysisoftheglobalbreakoutstudy AT changchuanhsun correctiontoprevalenceofmutationsinbrcaandhomologousrecombinationrepairgenesandrealworldstandardofcareofasianpatientswithher2negativemetastaticbreastcancerstartingfirstlinesystemiccytotoxicchemotherapysubgroupanalysisoftheglobalbreakoutstudy AT dalvitapashi correctiontoprevalenceofmutationsinbrcaandhomologousrecombinationrepairgenesandrealworldstandardofcareofasianpatientswithher2negativemetastaticbreastcancerstartingfirstlinesystemiccytotoxicchemotherapysubgroupanalysisoftheglobalbreakoutstudy AT walkergraham correctiontoprevalenceofmutationsinbrcaandhomologousrecombinationrepairgenesandrealworldstandardofcareofasianpatientswithher2negativemetastaticbreastcancerstartingfirstlinesystemiccytotoxicchemotherapysubgroupanalysisoftheglobalbreakoutstudy AT bennettjames correctiontoprevalenceofmutationsinbrcaandhomologousrecombinationrepairgenesandrealworldstandardofcareofasianpatientswithher2negativemetastaticbreastcancerstartingfirstlinesystemiccytotoxicchemotherapysubgroupanalysisoftheglobalbreakoutstudy AT oshaughnessyjoyce correctiontoprevalenceofmutationsinbrcaandhomologousrecombinationrepairgenesandrealworldstandardofcareofasianpatientswithher2negativemetastaticbreastcancerstartingfirstlinesystemiccytotoxicchemotherapysubgroupanalysisoftheglobalbreakoutstudy AT balmanajudith correctiontoprevalenceofmutationsinbrcaandhomologousrecombinationrepairgenesandrealworldstandardofcareofasianpatientswithher2negativemetastaticbreastcancerstartingfirstlinesystemiccytotoxicchemotherapysubgroupanalysisoftheglobalbreakoutstudy |